Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2014

View Archived Issues

Amarantus and Washington University School of Medicine collaborate in Wolfram syndrome

Servier and miRagen extend microRNA-targeting drug collaboration

BioLineRx in-licenses compound for neuropathic pain

Galectin Therapeutics reports preclinical data for GR-MD-02 from mouse model of NASH

Questcor Pharmaceuticals to acquire rights to Synacthen and Synacthen Depot

Discovery and characterization of novel broad-spectrum antibacterial agents

Phase I data for selective inhibitor of ACAT-1 in adrenocortical carcinoma

Safety and efficacy data reported for VRS-317, a novel long-acting rhGH

Testosterone levels increased for over 28 days in healthy men by lasofoxifene

A modified activin B propeptide to reverse activin-induced muscle wasting

Karyopharm's selinexor enters phase II trial in acute myeloid leukemia

Coherus' etanercept biosimilar enters phase III trial in rheumatoid arthritis

Auspex reports results from SD-809 switching study in Huntington's disease

Merck & Co. reports discovery of OX2 receptor antagonists

Chinese company discloses new cancer treatment

Lumacaftor/ivacaftor achieves endpoints in phase III cystic fibrosis trials

Sunshine Lake Pharma synthesizes novel HCV NS5A inhibitors

Novel FFA1 receptor agonists reported in Boehringer Ingelheim patent

French group details novel Na+/I- cotransporter inhibitors

Bionomics and Merck & Co. collaborate to develop BNC-375 for cognitive dysfunction

Catch-up growth seen with weekly injection of Lagova in phase II study

FDA advisory committee votes against accelerated approval of olaparib for ovarian cancer

Sobi files for E.U. approval of Xiapex for Peyronie's disease

Lundbeck completes acquisition of Chelsea Therapeutics

EMA accepts Ravicti MAA

FDA accepts Merck & Co.'s NDA for fixed-dose raltegravir and lamivudine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...